Blog | Novacana GmbH

Jul 3, 20221 min read

New Research on young adults' consumption of alcohol & cigarettes following cannabis legalisation

Research on the topic of cannabis, its affects on young adults and changed patterns of drug consumption post marijuana legalisation...

Apr 2, 20201 min read

Novacana receives narcotic drug and AMRadV approval

We are glad to announce that Novacana GmbH has received a narcotic drug license (German designation: BtM-Erlaubnis) approved by BfArM...

Mar 5, 20202 min read

Access to the German Market

In order to directly enter the German pharmaceutical market, a German entity with a Managing Director (MD) is required. As the German...

Mar 3, 20202 min read

AMRadV - Compliance

What is AMRadV? The regulatory regime overseeing the distribution of a medicinal cannabis in Germany is continuously changing. Cannabis...

Jan 16, 20202 min read

EU-GMP vs GACP

Qualification of medical-grade cannabis In Europe, medical cannabis products must comply with the relevant requirements laid down in the...